Satellos Bioscience Stock Quote MSCL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.495

Bid

0.49

Ask

0.52

Volume

20,189

0.49 Day's Range 0.51

0.38 52 Week Range 0.80

Market Cap

55.832M

Previous Close

0.50

Open

0.51

Last Trade

500

0.495

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

56,125

Shares Outstanding

112,792,000

Dividend Yield

PE Ratio

-3.48

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-15.89M

Sector

Coml Physical, Biologcl Resh

Industry

Pharmaceutical Preparations

Website

www.satellos.com

Headquarters

Toronto, Ontario, Can

Founded

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.50. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 0.80.

Satellos Bioscience currently has 112,792,000 shares outstanding. The market capitalization of Satellos Bioscience is $56.40 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -3.48.

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247

– Investigational New Drug (IND) enabling preclinical and toxicology studies successfully completed – Initiation of a Phase 1 clinical trial of SAT-3247 anticipated in Q3 2024 Satellos Bioscience...

Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy (“DMD”)

–SAT-3247 treatment improved muscle repair and regeneration in canine model of DMD – SAT-3247 treatment also improved muscle force in this canine model of DMD – Satellos remains on track to...

Satellos Announces Presentation at Parent Project Muscular Dystrophy (PPMD) 30th Annual Conference

– Frank Gleeson, Satellos CEO, to participate in a panel discussion titled "Research Row: PPMD Moving the Needle" on June 29, 2024 – Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX:...

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy

Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-1	0.5	0.51	0.47	24167	0.48243835	CS
4	-0.095	-16.1016949153	0.59	0.6	0.47	71281	0.51545667	CS
12	0.03	6.45161290323	0.465	0.64	0.38	56125	0.50772199	CS
26	-0.125	-20.1612903226	0.62	0.8	0.38	63972	0.54371363	CS
52	-0.125	-20.1612903226	0.62	0.8	0.38	63972	0.54371363	CS
156	-0.125	-20.1612903226	0.62	0.8	0.38	63972	0.54371363	CS
260	-0.125	-20.1612903226	0.62	0.8	0.38	63972	0.54371363	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUZENuZee Inc	$ 1.83 (77.67%)	686.5k
ALLRAllarity Therapeutics Inc	$ 0.285 (71.17%)	38.16M
NIVFNewGenIvf Group Ltd	$ 1.31 (50.42%)	4.08M
SLNASelina Hospitality PLC	$ 0.0313 (20.38%)	40.6M
DRMADermata Therapeutics Inc	$ 1.55 (19.23%)	96.58k
VSTMVerastem Inc	$ 2.73 (-23.96%)	381.66k
IONMAssure Holdings Corporation	$ 1.91 (-21.40%)	43.89k
CJETChijet Motor Company Inc	$ 4.20 (-17.32%)	89.02k
SLRXSalarius Pharmaceuticals Inc	$ 2.19 (-16.09%)	209.77k
ALPPAlpine 4 Holdings Inc	$ 0.513 (-14.49%)	296.92k
SLNASelina Hospitality PLC	$ 0.0313 (20.38%)	40.6M
ALLRAllarity Therapeutics Inc	$ 0.285 (71.17%)	38.16M
TSLATesla Inc	$ 232.00 (-5.84%)	13.71M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.13 (-11.46%)	11.91M
HOLOMicroCloud Hologram Inc	$ 0.5999 (2.58%)	8.78M